Organic Products & IP Focus
PsiloTec is developing a unique range of psilocybin therapy mushrooms with multiple layers of intellectual property (IP) protection, and all will be produced to the highest standards required when using Good Manufacturing Process (GMP) for organic products. Ongoing independent audits will confirm highest quality products.
PsiloTec is the only company to rapidly scale-up the number of sites available. It has a comprehensive program of continuous improvement to become the leader in remote therapy in the psychedelic market. It intends to make e-Clinics available to a range of psychedelic producers.
PsiloTec’s team has extensive experience in mycology, herbal medicine, neuroscience and clinical trials research. Proven leadership team in mycology and psilocybin mushroom growth.
Growing quality mushrooms to scale is complex.
Significant international experience and leading
expertise in all aspects of clinical mental health
research, including AI and new clinical trial approaches.
Clinical Trials Expertise
Comprehensive experience within the team of
more than 300 clinical studies in the mental
health space. Ability to design and complete
studies rapidly in multiple areas.
Will involve leading university-based
experts across multiple sites.
Artificial intelligence expertise which will be
applied to all aspects of e-Clinics
enhancing performance and outcomes.
This allows continuous improvements
in performance and outcome as
increased data improves AI performance.
Focus beyond basic psilocybin production, preventing risk of commoditization of
product and revenues.
Ongoing development of unique products, product combinations, and formulations
to increase revenue from multiple sources.